Dr. Matt Angel has led Factor Bioscience since its founding in 2011. A pioneer in mRNA technology development, Matt is a prolific inventor with more than 100 patents covering mRNA, nucleic acid delivery, gene editing, and cell reprogramming technologies. Matt is a serial entrepreneur, and is Co-Founder of immuno-oncology company, Exacis Biotherapeutics, where he serves as Director and Scientific Advisory Board Chair, and the recently acquired cell therapy company, Novellus Therapeutics.

Matt received his Ph.D. from the Massachusetts Institute of Technology, where he studied the innate immune response of cells to exogenous RNA molecules. Prior to his graduate studies, Matt was a member of MIT Lincoln Laboratory’s Biodefense Systems Group, where he developed technologies to detect and mitigate biological weapons threats.